Safety and Efficacy of Rasagiline in Restless Legs Syndrome.

Trial Profile

Safety and Efficacy of Rasagiline in Restless Legs Syndrome.

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 08 Feb 2013

At a glance

  • Drugs Rasagiline (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Acronyms RAS-RLS
  • Most Recent Events

    • 08 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 27 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 06 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top